Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory Study of Prednisolone Tapering and Discontinuation Based on Adrenal Function Recovery in SLE Remission
jRCT1031250833Recruiting
- Start
- Mar 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of prednisolone in systemic lupus erythematosus (SLE). Primary endpoint: SLE relapse rate up to Week 52. Started Mar 2026; status: recruiting.
02
Drugs
prednisolone
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on jRCT1031250833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031250833.